Author:
Baran-Kooiker Aleksandra,Czech Marcin,Kooiker Coen
Subject
Public Health, Environmental and Occupational Health
Reference63 articles.
1. Challenges in the economic evaluation of orphan drugs
DrummondMF
Eurohealth2008
2. Health technologies for rare diseases: does conventional HTA still apply?;Simoens;Expert Rev Pharmacoecon Outcomes Res,2014
3. Challenges in using MCDA for reimbursement decisions on new medicines?;Walker;Value Health,2016
4. Multi-criteria decision analysis (MCDA) and its alternatives in health technology assessment;Vorobiev;JHPOR,2015
5. Rare Disease and Clinical Trials (04.11.2014)
PariserA